Abstract:Editor, R ecent reports have shown favourable short-term results with intravitreal bevacizumab (Avastin ; Genetech, San Francisco, California, USA) in the treatment of proliferative diabetic retinopathy (PDR). However, aggravation of PDR related to this relatively recent method of treatment has not been known. We encountered a case with development of multiple retinal haemorrhages after intravitreal bevacizumab as an adjunctive treatment to pars plana vitrectomy in PDR. A diabetic 65-year-old woman presented with aggravating vitreous haemorrhage after panretinal photocoagulation (PRP) with corrected vision of 20 ⁄ 400 and was scheduled for surgery. Right eye fundus showed vitreous haemorrhage and faintly visible multiple dot-shaped retinal haemorrhages (Fig. 1A). Combined pars plana vitrectomy, phacoemulsification with intraocular lens implantation, endolaser PRP and intravitreal injection of 1.25 mg bevacizumab at the end of surgery were performed. On postoperative day 7, her right eye showed newly developed multiple, extensive retinal haemorrhages at entire fundus (Fig. 1B) with corrected vision of 20 ⁄400 and intraocular pressure of 10 mmHg. Her systemic factors, including glycemic control, blood pressure and serum lipid levels, had been stable. On her visit 9 months after surgery, retinal haemorrhages were much resolved, but corrected vision still remained at 20 ⁄ 200 (Fig. 2). We are unaware of previous reports in PubMed regarding the development of multiple retinal haemorrhages after intravitreal bevacizumab. We used 1.25 mg of bevacizumab, but considering that our case was a vitrectomized eye, actual effective dose may have been less because of rapid clearance from the vitreous cavity. No postsurgical complications of combined cataract surgery and vitrectomy (such as hypotony) were present, which could otherwise explain the development of retinal haemorrhages. Risk of haemorrhage with the use of bevacizumab has been known, especially in systemic treatment in oncology. Systemic bevacizumab for cancer therapy has promoted bleeding from mucocutaneous membranes in 20–40% of patients (BC Cancer Agency 2006). The development of metrorrhagia in a healthy nulliparous 35-year-old woman after 2 weeks of intravitreal bevacizumab for the treatment of disc neovascularization with branched retinal vein occlusion has been reported recently (Rodrigues et al. 2007). Bevacizumab is a monoclonal antibody against all isoforms of vascular endothelial growth factor (VEGF). VEGF is a regulator of endothelial cell function in proliferation, migration, differentiation and even survival (Ferrara 1999). Recent experiments in animals have suggested a central role for the 165 isoform of VEGF, specifically in the pathogenesis of diabetic macular oedema (DMO) (Qaum et al. 2001). Pegaptanib sodium injection (Macugen ; Eyetech Pharmaceuticals Inc., New York, USA), which was known to selectively block the activity of VEGF165 isoform, resulted in visual acuity gain, decrease in retinal thickness and less need for focal ⁄ grid laser intervention in DMO (Macugen Diabetic Retinopathy Study Group 2005). Blocking of physiological isoforms of VEGF, as well as pathological isoforms, with bevacizumab might (A) (B)

Situational Context is Important: Perceptual Grouping Modulates Temporal Perception

Modulations of Temporal Perception by Consciously and Unconsciously Perceived Stimuli

Attention Does Not Play a Role in Chronostasis Effect

Perceptual confidence of visual stimulus features is associated with duration perception

How Long Did I Wait? the Effect of Construal Levels on Consumers' Wait Duration Judgments

Duration Comparisons for Vision and Touch Are Dependent on Presentation Order and Temporal Context

Temporal context modulates cross-modality time discrimination: Electrophysiological evidence for supramodal temporal representation

EXPRESS: Influences of Temporal and Probabilistic Expectation on Subjective Time of Emotional Stimulus

The Speed and Temporal Frequency of Visual Apparent Motion Modulate Auditory Duration Perception

Visual feature processing in the early visual cortex affects duration perception.

Temporal perception in visual processing as a research tool.

Adaptation to Temporal Interval Modulates the Perception of Visual Apparent Motion

Adaptation to Visual or Auditory Time Intervals Modulates the Perception of Visual Apparent Motion

Measuring the perception and metacognition of time

Changes in the experience of time: The impact of spatial information on the perception and memory of duration

Subjective present: a window of temporal integration indexed by mismatch negativity

Odors Bias Time Perception in Visual and Auditory Modalities.

The temporal transition zone: A gradual approach to a subjective set‐point within the three‐second time window

Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin®) with pars plana vitrectomy

The Role of Spatiotemporal and Spectral Cues in Segregating Short Sound Events: Evidence from Auditory Ternus Display

Gaze-Triggered Communicative Intention Compresses Perceived Temporal Duration